https://orcid.org/0000-0001-7860-1779
References
- Potthoff A , Dreisewerd, K, SoltwischJet al. Detailed characterization of the postionization efficiencies in MALDI-2 as a function of relevant input parameters. J. Am. Soc. Mass Spectrom.31, 1844–1853 (2020).
- Niehaus M , SoltwischJ, BelovMEet al. Transmission-mode MALDI-2 mass spectrometry imaging of cells and tissues at subcellular resolution. Nat. Methods16, 925–931 (2019).
- Spraggins JM , DjambazovaKV, RiveraESet al. High-performance molecular imaging with MALDI trapped ion-mobility time-of-flight (timsTOF) mass spectrometry. Anal. Chem.91, 14552–14560 (2019).
- Källback P , VallianatouT, NilssonAet al. Cross-validated matrix-assisted laser desorption/ionization mass spectrometry imaging quantitation protocol for a pharmaceutical drug and its drug-target effects in the brain using time-of-flight and Fourier transform ion cyclotron resonance analyzers. Anal. Chem.92, 14676–14684 (2020).
- Norris JL , GutierrezDB, CaprioliRMet al. Imaging mass spectrometry in clinical pathology. In: Diagnostic Molecular Pathology517–529 (2017).
- Calligaris D , NortonI, FeldmanDRet al. Mass spectrometry imaging as a tool for surgical decision-making. J. Mass Spectrom.48, 1178–1187 (2013).
- Lee DK , RubakhinSS, KusmartsevaIet al. Removing formaldehyde-induced peptidyl crosslinks enables mass spectrometry imaging of peptide hormone distributions from formalin-fixed paraffin-embedded tissues. Angewandte Chem. Int. Edition59, 22584–22590 (2020).
- Shariatgorji M , NilssonA, FridjonsdottirEet al. Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. Nat. Methods16, 1021–1028 (2019).
- Vallianatou T , ShariatgorjiM, NilssonAet al. Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition. Neuropsychopharmacology44, 2091–2098 (2019).
- Achanta NSK , HarithaANV, TekadeRKet al. Mass spectrometry imaging in lipid and proteomic profiling: an emerging tool for cancer diagnosis. In: The Future of Pharmaceutical Product Development and Research,259–295 (2020).
- Fridjonsdottir E , ShariatgorjiR, NilssonAet al. Mass spectrometry imaging identifies abnormally elevated brain L-DOPA levels and extrastriatal monoaminergic dysregulation in L-DOPA-induced dyskinesia. Sci. Adv.7(2), 1 (2021).
- Kaya I , JennischeE, LangeSet al. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer’s disease mice. J. Neurochem.154, 84–98 (2020).
- Blanc L , LenaertsA, DartoisVet al. Visualization of mycobacterial biomarkers and tuberculosis drugs in infected tissue by MALDI-MS imaging. Anal. Chem.90, 6275–6282 (2018).
- Ntshangase S , MdandaS, SinghSDet al. Mass spectrometry imaging demonstrates the regional brain distribution patterns of three first-line antiretroviral drugs. ACS Omega4, 21169–21177 (2019).
- Baijnath S , MoodleyC, NgcoboBet al. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model. Int. J. Antimicrob. Agents51, 77–81 (2018).
- Ovchinnikova K , StuartL, RakhlinAet al. ColocML: machine learning quantifies co-localization between mass spectrometry images. Bioinformatics36, 3215–3224 (2020).
- Van de Plas R , YangJ, SpragginsJet al. Image fusion of mass spectrometry and microscopy: a multimodality paradigm for molecular tissue mapping. Nat. Methods12, 366–372 (2015).